BioLineRx (NASDAQ: BLRX) announced that it has priced an underwritten public offering of 12,500,000 American Depositary Shares (“ADSs”), each representing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE